Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
Drug Insights
4 min read
Deep Scientific Insights on interferon beta-1b's R&D Progress, Mechanism of Action, and Drug Target
18 October 2023
This article summarized the latest R&D progress of interferon beta-1b, the Mechanism of Action for interferon beta-1b, and the drug target R&D trends for interferon beta-1b.
R&D Pipeline
2 min read
Latest Competitive Analysis of AbbVie Drug Pipeline
18 October 2023
Since acquiring Allergan, AbbVie has experienced a period of stable performance, but this year has seen a significant decline in the performance of its two heavyweight drugs, Adalimumab and Ibrutinib.
Drug Insights
5 min read
An In-depth Analysis of itopride hydrochloride's R&D Progress and Mechanism of Action on Drug Target
18 October 2023
This article summarized the latest R&D progress of itopride hydrochloride, the Mechanism of Action for itopride hydrochloride, and the drug target R&D trends for itopride hydrochloride
Latest Hotspot
3 min read
Rivus Pharmaceuticals' HU6 2a trial showed positive outcomes in treating high BMI individuals with Non-alcoholic Fatty Liver Disease
18 October 2023
The 2a trial of Rivus Pharmaceuticals' experimental metabolic booster, HU6, yielded promising results in treating High BMI individuals with Non-alcoholic Fatty Liver Disease.
Drug Insights
4 min read
laquinimod: Detailed Review of its Transformative R&D Success, Mechanism of Action, and Drug Target
18 October 2023
This article summarized the latest R&D progress of laquinimod, the Mechanism of Action for laquinimod, and the drug target R&D trends for laquinimod.
Bio Sequence
2 min read
Finding the Complete Antibody Sequence Using a Known CDR Sequence: An Exploration with Patsnap Bio Sequence Database
18 October 2023
One can elucidate the entire antibody sequence by utilizing a known Complementarity-determining region (CDR) sequence in combination with the accessible Patsnap Bio Sequence Database.
R&D Pipeline
2 min read
Latest Competitive Analysis of Merck Sharp & Dohme Drug Pipeline
18 October 2023
Merck's recent revenue performance remains steady, with the K drug continuing to grow and earning the title of "New Generation Drug King".
Latest Hotspot
4 min read
Avidity Biosciences presents encouraging results for AOC 1001, showing progress and long-term safety in multiple areas for Type 1 Myotonic Dystrophy patients
18 October 2023
Avidity Biosciences Reports Fresh Positive Results for AOC 1001, Showing Progress in Various Additional Functional Measures and Long-term Safety and Acceptability in Individuals with Type 1 Myotonic Dystrophy.
Bio Sequence
2 min read
Reducing the Risk of FTO Missed Detection in Special Referential Sequences of Patents
18 October 2023
The patent and literature contain sequences of nucleic acids containing N and protein sequences containing X. I'm interested in reducing the risk of missing such sequences. Is there a recommended database where I can search for these sequences?
Drug Insights
5 min read
Epalrestat Unveiled: A Detailed Overview of its Revolutionary R&D Breakthroughs
18 October 2023
This article summarized the latest R&D progress of epalrestat, the Mechanism of Action for epalrestat, and the drug target R&D trends for epalrestat.
Bio Sequence
2 min read
Unveiling the FTO Retrieval of Multi-gene Elements within the AAV Domain
18 October 2023
In the AAV field, common inventions involve the replacement and combination of expression-related gene regulatory elements.
Latest Hotspot
3 min read
The FDA has granted approval for TOFIDENCE™ (tocilizumab-bavi), a biosimilar of ACTEMRA®, created by Bio-Thera Solutions
18 October 2023
Bio-Thera Solutions has made it known that its associate company, Biogen, was recently notified by FDA about the approval of TOFIDENCE (tocilizumab-bavi) in an intravenous mixture.